IPSTRAUC : Impact on Care Pathways of a New Management of Cervical Trauma in Conscious Patients Stable in Pre-hospital Care

NCT ID: NCT06983873

Last Updated: 2026-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

840 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-28

Study Completion Date

2030-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the application of Canadian C-Spine rules adapted to pre-hospital settings in France in order to improve the appropriateness of cervical spine immobilisation, reduce unnecessary imaging examinations and optimise patient care pathways.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to assess the feasibility and effectiveness of applying the Canadian C-Spine rules adapted (CCRa) to the pre-hospital context of the French healthcare system. The hypothesis is that the use of these rules will improve the appropriateness of cervical collar use, reduce the need for imaging examinations, reduce referrals to emergency departments and ensure the identification of patients really at risk of cervical spine injury. Collaboration between primary care providers, including the fire service, emergency medical services (EMS) and general practitioners, will be crucial to successful implementation.

As part of routine care, each time the fire brigade is called out to deal with a health problem, it carries out an assessment at the SAMU (emergency medical service) to decide how the patient should be referred and treated. During this assessment and call, patients meeting the inclusion criteria of our study will be selected. After inclusion, patients will be assessed by a firefighter or SMUR physician specifically trained in CCRa rules in addition to the study training. Following application of the CCRa rules, the final decision on immobilisation will be taken by an investigating physician from the EMS in consultation with the study-trained professional taking charge of the patient. If the CCRa accept the indication for a cervical collar, immobilisation will be performed and the patient will be referred to the emergency department of the investigating centre. When the decision rules do not include an indication for cervical imaging, the patient will not be immobilised with a cervical collar. In this second case, patients will not be referred to A\&E unless they have another reason for being referred to A\&E. All patients included in the study will be recalled 14 and 30 days after their trauma to collect data about their healthcare consumption. At day 14, answers to a questionnaire focusing on cervical lesion suspicion are also collected. If there is a suspicion of a lesion in the answers to the questionnaire , the patient will be called in by the investigating centre for a medical examination and more detailed imaging tests. In parallel, the practices and organizations of firefighters in the fire stations will be evaluated before the start of inclusions and the feasibility and reproducibility of implementing CCRa as part of the pre-hospital care organisation of the French healthcare system will be determined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prehospital Emergency Neck Injury Neck Trauma Emergency Medical Services

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CCRa

Pre-hospital management follow the rules of CCRa for all patients included in all sites ranodmized in the CCRa arm

Group Type EXPERIMENTAL

adapted Canadian C-Spine rules

Intervention Type BEHAVIORAL

The CCRa are decision rules for pre-hospital cervical spine collar immobilization. They include three high-risk criteria indicating imaging, 5 low-risk criteria allowing assessment of cervical spine rotation, and finally the ability of patients to achieve limited active rotation. They have been designed and validated to avoid immobilization during transport to the emergency department without any significant cervical injury being missed.

Control

Patients included from all sites randomized in the control arm will be assessed according to standard practice

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

adapted Canadian C-Spine rules

The CCRa are decision rules for pre-hospital cervical spine collar immobilization. They include three high-risk criteria indicating imaging, 5 low-risk criteria allowing assessment of cervical spine rotation, and finally the ability of patients to achieve limited active rotation. They have been designed and validated to avoid immobilization during transport to the emergency department without any significant cervical injury being missed.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PATIENTS

* GCS 15
* Stable (no organ failure, SBP ≥ 90 mmHg, DBP ≥ 65 mmHg, RF between 10 and 24 cycles/min)
* Cooperative (calm and obedient to instructions)
* Victim of a closed cervical spine trauma treated in the pre-hospital setting (fire brigade and/or Mobile Emergency and Resuscitation Service (SMUR)).
* Recent trauma (\< 48 hours).
* Care regulated by the Emergency Medical Service (SAMU).
* Beneficiary of a social security scheme.
* Who can be contacted by telephone
* Have received oral and written information and have not objected to taking part in the study.

PROFESSIONAL

* Age ≥ 18 years
* Professional firefighter or EMS regulating doctor
* Professional who has received training in the protocol and, in the case of the experimental group, in the CCRa rules
* Fluency in French
* Having received oral and written information and not having objected to their participation in the study.

Exclusion Criteria

PATIENTS

* Life-threatening organ damage
* Cardiorespiratory arrest since the traumatic event in question
* Polytrauma patient
* Penetrating trauma or a supra-clavicular wound following a knife or firearm injury
* Known spinal disease or previous spinal surgery (ankylosing spondylitis, rheumatic fever, spinal stenosis, cervical spine surgery).
* Acute paralysis (paraplegia, tetraplegia, hemiplegia, hemiparesis or documented sensory or motor deficit)
* Diagnosed osteogenesis imperfecta.
* Patients not regulated by EMS or transported to a hospital not participating in the study
* Pregnant or breast-feeding women
* Known situation of deprivation of liberty (safeguard of justice), guardianship or curatorship

PROFESSIONALS

\- Persons referred to in articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g. minors, protected adults, persons deprived of their liberty, persons under guardianship, curatorship, etc.).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François Saget, Md

Role: PRINCIPAL_INVESTIGATOR

CHU Rennes / Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens-Picardie

Amiens, , France

Site Status

CHRU Besançon

Besançon, , France

Site Status

Centre Hospitalier Sud-Francilien

Corbeil-Essonnes, , France

Site Status

Hôpitaux La Rochelle Ré Aunis

La Rochelle, , France

Site Status

AP-HM Timone

Marseille, , France

Site Status

CHRU Nancy

Nancy, , France

Site Status

CHU Nice

Nice, , France

Site Status

CHU Poitiers

Poitiers, , France

Site Status

CHU Reims

Reims, , France

Site Status

CHU Rennes

Rennes, , France

Site Status

CHU Toulouse

Toulouse, , France

Site Status

Centre hospitalier Bretagne Atlantique

Vannes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marie-Laure Gervais, PhD

Role: CONTACT

2 99 28 25 91 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emilien Arnaud

Role: primary

+33 (0)322088790

Justin Outrey

Role: primary

+33 (0)381668117

Jean-Philippe Desclefs

Role: primary

+33 (0)161696169

Ombeline Susong

Role: primary

+33 (0)546455050

Justine AUDOUARD

Role: primary

+33 (0)491384515

Tahar CHOUIHED

Role: primary

+33 (0)383851496

Julie Contenti

Role: primary

+33 (0)492033242

Nicolas MARJANOVIC

Role: primary

+33 (0)5 49 44 44 44

Stéphane Gennai

Role: primary

+33(0)326787602

François Saget, Md

Role: primary

+33 (0)299284321

Vincent Levrel, Md

Role: backup

+33 (0)299284321

Xavier Dubucs

Role: primary

+33(0)561775919

Bertrand Boulanger

Role: primary

+33 (0)297014141

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A00636-41

Identifier Type: OTHER

Identifier Source: secondary_id

35RC22_8872_IPSTRAUC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stem Cells in Spinal Cord Injury
NCT03935724 UNKNOWN PHASE2/PHASE3